Abandoning established pharmaceutical products for a "staking-driven revenue model" based on digital tokens isn't a visionary pivot, but a desperate gamble that replaces tangible value with speculative protocol activity. How can a company generate sustainable returns without traditional business operations?
This summary was generated by AI
NovaBay Stock•Crypto Self Governance•NovaBay Crypto Strategy•NovaBay•SKY Token•Defi•Stablecoin•SKY Protocol•NBY
1